Characterization of the glutathione conjugate of the semisynthetic flavonoid monoHER

Free Radical Biology and Medicine

Volumn 46, Issue 12, 2009, Pages 1567-1573

  Jacobs, Hilde ^a   van der Vijgh, Wim J F ^a   Koek, Ger H ^b   Draaisma, Guy J J ^c   Moalin, Mohamed ^c   van Strijdonck, Gino P F ^c   Bast, Aalt ^a   Haenen, Guido R M M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ZUYD UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

7 Mono O ( hydroxyethyl)rutoside; Antioxidant; Flavonoid; Free radicals; Glutathione; Oxidation; Thiol

Indexed keywords

2'' GLUTATHIONYLMONOHYDROXYETHYLRUTOSIDE; 7 MONO O (BETA HYDROXYETHYL)RUTOSIDE; GLUTATHIONE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; MONOXERUTIN; RUTOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; DRUG CONJUGATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MASS SPECTROMETRY; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; BILE; BODY FLUIDS; COMPUTER SIMULATION; GLUTATHIONE; HORSERADISH PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; HYDROXYETHYLRUTOSIDE; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MODELS, CHEMICAL; OXIDATION-REDUCTION; QUANTUM THEORY; REFERENCE VALUES; SOLID PHASE EXTRACTION; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

ARMORACIA RUSTICANA;

EID: 67349275287     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.02.031     Document Type: Article

References (35)

1. Ren W., Qiao Z., Wang H., Zhu L., and Zhang L. Flavonoids: promising anticancer agents. Med. Res. Rev 23 (2003) 519-534
2. Nichenametla S.N., Taruscio T.G., Barney D.L., and Exon J.H. A review of the effects and mechanisms of polyphenolics in cancer. Crit. Rev. Food Sci. Nutr. 46 (2006) 161-183
3. van Acker F.A., Schouten O., Haenen G.R., van der Vijgh W.J., and Bast A. Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett 12 (2000) 145-148
4. Cushnie T.P., and Lamb A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26 (2005) 343-356
5. Choi J.A., Kim J.Y., Lee J.Y., Kang C.M., Kwon H.J., Yoo Y.D., Kim T.W., Lee Y.S., and Lee S.J. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol 19 (2001) 837-844
6. Naasani I., Oh-Hashi F., Oh-Hara T., Feng W.Y., Johnston J., Chan K., and Tsuruo T. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res 63 (2003) 824-830
7. Park H.H., Lee S., Oh J.M., Lee M.S., Yoon K.H., Park B.H., Kim J.W., Song H., and Kim S.H. Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol. Res 55 (2007) 31-37
8. Boots A.W., Wilms L.C., Swennen E.L., Kleinjans J.C., Bast A., and Haenen G.R. In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24 (2008) 703-710
9. Bast A., and Haenen G.R. The toxicity of antioxidants and their metabolites. Environ. Toxicol. Pharmacol 11 (2002) 251-258
10. Haenen G.R., and Bast A. The use of vitamin supplements in self-medication. Therapie 57 (2002) 119-122
11. Galati G., Sabzevari O., Wilson J.X., and O'Brien P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177 (2002) 91-104
12. Boots A.W., Haenen G.R., den Hartog G.J., and Bast A. Oxidative damage shifts from lipid peroxidation to thiol arylation by catechol-containing antioxidants. Biochim. Biophys. Acta 1583 (2002) 279-284
13. Laughton M.J., Halliwell B., Evans P.J., and Hoult J.R. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin: effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem. Pharmacol 38 (1989) 2859-2865
14. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaite E., and Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 26 (1999) 107-116
15. Boots A.W., Kubben N., Haenen G.R., and Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem. Biophys. Res. Commun 308 (2003) 560-565
16. Galati G., Moridani M.Y., Chan T.S., and O'Brien P.J. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radic. Biol. Med. 30 (2001) 370-382
17. Awad H.M., Boersma M.G., Vervoort J., and Rietjens I.M. Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. Arch. Biochem. Biophys 378 (2000) 224-233
18. Boots A.W., Balk J.M., Bast A., and Haenen G.R. The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity. Biochem. Biophys. Res. Commun 338 (2005) 923-929
19. Boots A.W., Li H., Schins R.P., Duffin R., Heemskerk J.W., Bast A., and Haenen G.R. The quercetin paradox. Toxicol. Appl. Pharmacol 222 (2007) 89-96
20. Haenen G.R., Jansen F.P., and Bast A. The antioxidant properties of five O-(-β-hydroxyethyl)-rutosides of the flavonoid mixture Venoruton. Phlebology Suppl 1 (1993) 10-17
21. van Acker S.A., Towart R., Husken B.C., De Jong J., van der Vijgh W.J., and Bast A. The protective effect of Venoruton and its main constituents on acute doxorubicin-induced cardiotoxicity. Phlebology Suppl 1 (1993) 31-32
22. Petruzzellis V., Troccoli T., Candiani C., Guarisco R., Lospalluti M., Belcaro G., and Dugall M. Oxerutins (Venoruton): efficacy in chronic venous insufficiency-a double-blind, randomized, controlled study. Angiology 53 (2002) 257-263
23. Wadworth A.N., and Faulds D. Hydroxyethylrutosides: a review of its pharmacology and therapeutic efficacy in venous insufficiency and related disorders. Drugs 44 (1992) 1013-1032
24. Abou El Hassan M.A., Verheul H.M., Jorna A.S., Schalkwijk C., van Bezu J., van der Vijgh W.J., and Bast A. The new cardioprotector monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro. Br. J. Cancer 89 (2003) 357-362
25. Bruynzeel A.M., Abou El Hassan M.A., Schalkwijk C., Berkhof J., Bast A., Niessen H.W., and van der Vijgh W.J. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. Br. J. Cancer 96 (2007) 937-943
26. van Acker F.A., van Acker S.A., Kramer K., Haenen G.R., Bast A., and van der Vijgh W.J., 7-Monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin. Cancer Res 6 (2000) 1337-1341
27. Willems A.M., Bruynzeel A.M., Kedde M.A., van Groeningen C.J., Bast A., van der Vijgh W.J., and A phase I. study of monohydroxyethylrutoside in healthy volunteers. Cancer Chemother. Pharmacol. 57 (2006) 678-684
28. Bruynzeel A.M., Niessen H.W., Bronzwaer J.G., van der Hoeven J.J., Berkhof J., Bast A., van der Vijgh W.J., and van Groeningen C.J. The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study. Br. J. Cancer 97 (2007) 1084-1089
29. Koek G.H., Vos R., Flamen P., Sifrim D., Lammert F., Vanbilloen B., Janssens J., and Tack J. Oesophageal clearance of acid and bile: a combined radionuclide, pH, and Bilitec study. Gut 53 (2004) 21-26
30. Galati G., Chan T., Wu B., and O'Brien P.J. Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redox cycling of flavonoids. Chem. Res. Toxicol 12 (1999) 521-525
31. Heijnen C.G., Haenen G.R., Oostveen R.M., Stalpers E.M., and Bast A. Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radic. Res. 36 (2002) 575-581
32. van Acker S.A., van den Berg D.J., Tromp M.N., Griffioen D.H., van Bennekom W.P., van der Vijgh W.J., and Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20 (1996) 331-342
33. Rice-Evans C.A., Miller N.J., and Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20 (1996) 933-956
34. Lien E.J., Ren S., Bui H.H., and Wang R. Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic. Biol. Med. 26 (1999) 285-294
35. Jones D.J., Lamb J.H., Verschoyle R.D., Howells L.M., Butterworth M., Lim C.K., Ferry D., Farmer P.B., and Gescher A.J. Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity. Br. J. Cancer 91 (2004) 1213-1219